FDA DrugClass IINotable

FDA Recall: Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg

Date: 2026-04-01
Brand: Amerisource Health Services LLC
Category: Drug
FDA Class: Class II

Description

Failed tablet specifications.

Hazard

Failed tablet specifications.

Remedy

697 cartons

View original recall →
Share:

Related Recalls

2026-05-06 · FDA_DRUG
FDA Recall: Similasan, iVIZIA, Sterile Lubricant Eye Drops (Povidone 0.5%), 0.33 Fl oz (10 mL), Made in France,
Thea Pharma, Inc.
2026-05-06 · FDA_DRUG
FDA Recall: Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial, For intravenous use, Rx O
American Regent, Inc.
2026-05-06 · FDA_DRUG
FDA Recall: GenTeal Tears, Lubricant Eye Gel, Sterile, 10g (0.34 Fl oz), Distributed by: Alcon Laboratories, Inc
Alcon Research LLC
2026-05-06 · FDA_DRUG
FDA Recall: fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg p
Wells Pharma of Houston LLC
FDA Recall: Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg | WatchRecall